Aprea Therapeutics, Inc. APRE
NASDAQ · United States · Health Technology
$0.7240-0.03 (-3.47%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-12 | -0.07 | -0.18 | +60.6% | $0 | -100.0% | +1.7%$0.66→$0.67 |
| Q1 2026 | 2026-05-13 | -0.22 | -0.23 | +4.3% | — | — | +4.6%$0.90→$0.94 |
| Q4 2025 | 2026-03-16 | -0.32 | -0.36 | +11.1% | — | — | +6.3%$0.74→$0.78 |
| Q3 2025 | 2025-11-12 | -0.47 | -0.34 | -38.2% | — | — | -9.8%$1.32→$1.19 |
| Q2 2025 | 2025-08-12 | -0.53 | -0.71 | +25.4% | — | — | — |
| Q4 2024 | 2025-03-25 | -0.49 | -0.54 | +9.3% | — | — | — |
| Q2 2024 | 2024-08-12 | -0.58 | -0.60 | +3.3% | — | — | — |
| Q1 2024 | 2024-05-14 | -0.67 | -0.80 | +16.3% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.